Leguisan, Mario M.

HRN: 28-04-73  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/04/2025
MUPIROCIN 2%, 15G (TUBE)
11/04/2025
11/10/2025
TOPICAL
APLLY ON AFFECTED AREA
BID
Infected Wound
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: